To the editor:

Nitric oxide (NO) is involved in the modulation of multiple physiologic functions. NO is produced from L-Arg by the catalytic action of NO synthase (NOS; EC 1.14.13.39).1  Erythrocytes have been reported to express NOS,2-8  an eNOS isoform.5  However, findings on a functional erythrocytic eNOS (eeNOS) in humans are contradictory.2-8  Discrepancies may be because of different experimental conditions and methodological shortcomings.9  In consideration of the paradoxical occurrence of eeNOS in red blood cells (RBCs),6  which are mainly responsible for NO inactivation,9  we attempted to measure NOS activity in RBCs freshly collected from normal healthy humans by a fully validated, highly sensitive and specific gas chromatography-mass spectrometry (GC-MS) assay.10  Approval from the local Ethics Committee of the Hannover Medical School was obtained. Blood was drawn from the antecubital vein of healthy male and female volunteers using EDTA monovettes and processed immediately. RBCs were separated by centrifugation (800g, 4°C, 5 minutes) and used either unwashed or after repeated wash with physiologic saline. Unwashed RBCs were lyzed by freezing (30 minutes, −80°C) followed by slow defrosting in an ice bath and by rapid vortex-mixing (1 minute) with ice-cold distilled water (1:1, vol/vol).

Both in whole blood and in washed RBCs, externally added L-[guanidine-15N2]-arginine (L-[15N2]-Arg; Figure 1A) but not 15NO-derived [15N]nitrite and [15N]nitrate (not shown) was detected in RBCs cytosol at concentrations comparable with erythrocytic L-Arg concentrations. In washed RBCs isolated from blood of a healthy female volunteer, the peak area ratio (PAR) of m/z 47 ([15N]nitrite) to m/z 46 ([14N]nitrite) and the PAR of m/z 63 ([15N]nitrate) to m/z 62 ([14N]nitrate) measured in the RBCs cytosol did not differ between untreated and L-[15N2]-Arg-treated RBCs (Figure 1B). These findings suggest no formation of 15NO from L-[15N2]-Arg by native RBCs.

Figure 1

Uptake of L-[15N2]-Arg in RBCs and assessment of NO synthase and glutathione reductase activity in intact and lyzed human RBCs. Enrichment of L-[15N2]-Arg (A), [15N]nitrite, [15N]nitrate and L-[15N2]-Arg (B) in RBCs cytosol after incubation of L-[15N2]-Arg with whole blood and washed RBCs of 2 healthy volunteers (A,B); NOS activity in lyzed human RBCs in the absence and in the presence of externally added heNOS (C); glutathione reductase (GR) activity in lyzed human RBCs (D). (A) Peak area ratio (PAR) of m/z 588 to m/z 586 after incubation of whole blood and washed RBCs with L-[guanidine-15N2]-arginine (L-[15N2]-Arg; 98% at both 15N atoms; Cambridge Isotope Labs). L-[15N2]-Arg (10mM with respect to the blood volume) was incubated for 20 minutes at 37°C. In case of washed RBCs, the original blood plasma volume was replaced by the same volume of physiologic saline or physiologic saline that contained glucose (1mM). The blood used in this experiment was donated by a healthy, 27-years old male volunteer. (B) PAR of m/z 47 to m/z 46 (for [15N]nitrite), m/z 63 to m/z 62 (for [15N]nitrate) and m/z 588 to m/z 586 (for L-[15N2]-Arg) on incubation of washed RBCs with L-[15N2]-Arg (0.4mM with respect to the blood volume) for 20 minutes at 37°C. The original blood plasma volume was replaced by physiologic saline that contained glucose (1mM). Blood used in this experiment was donated by a healthy, 28-years old female volunteer. Note the logarithmic scale on the y axis. (C) PAR of m/z 63 to m/z 62 measured in lyzed RBCs isolated from EDTA blood donated by 5 healthy volunteers (aged 28–56 years; 4 females). Lyzed RBCs were incubated with L-[15N2]-Arg (5mM) in the absence (open symbol) or in the presence (closed symbol) of externally added recombinant heNOS (50 μg/mL; ALEXIS). Incubations were performed at 37°C. Data are shown as mean ± SEM. Asterisks indicate statistically significant difference between incubation time 0 minutes and incubation time 10 minutes (P = .029), incubation time 20 minutes (P = .021) and incubation time 30 minutes (P = .016). (D) Decrease in the concentration of externally added NADPH (100μM) in lyzed RBCs diluted with phosphate buffered saline (1:200, vol/vol) after addition of the substrate GSSG (1mM). NADPH was measured spectrophotometrically by recording absorbance at 340 nm.

Figure 1

Uptake of L-[15N2]-Arg in RBCs and assessment of NO synthase and glutathione reductase activity in intact and lyzed human RBCs. Enrichment of L-[15N2]-Arg (A), [15N]nitrite, [15N]nitrate and L-[15N2]-Arg (B) in RBCs cytosol after incubation of L-[15N2]-Arg with whole blood and washed RBCs of 2 healthy volunteers (A,B); NOS activity in lyzed human RBCs in the absence and in the presence of externally added heNOS (C); glutathione reductase (GR) activity in lyzed human RBCs (D). (A) Peak area ratio (PAR) of m/z 588 to m/z 586 after incubation of whole blood and washed RBCs with L-[guanidine-15N2]-arginine (L-[15N2]-Arg; 98% at both 15N atoms; Cambridge Isotope Labs). L-[15N2]-Arg (10mM with respect to the blood volume) was incubated for 20 minutes at 37°C. In case of washed RBCs, the original blood plasma volume was replaced by the same volume of physiologic saline or physiologic saline that contained glucose (1mM). The blood used in this experiment was donated by a healthy, 27-years old male volunteer. (B) PAR of m/z 47 to m/z 46 (for [15N]nitrite), m/z 63 to m/z 62 (for [15N]nitrate) and m/z 588 to m/z 586 (for L-[15N2]-Arg) on incubation of washed RBCs with L-[15N2]-Arg (0.4mM with respect to the blood volume) for 20 minutes at 37°C. The original blood plasma volume was replaced by physiologic saline that contained glucose (1mM). Blood used in this experiment was donated by a healthy, 28-years old female volunteer. Note the logarithmic scale on the y axis. (C) PAR of m/z 63 to m/z 62 measured in lyzed RBCs isolated from EDTA blood donated by 5 healthy volunteers (aged 28–56 years; 4 females). Lyzed RBCs were incubated with L-[15N2]-Arg (5mM) in the absence (open symbol) or in the presence (closed symbol) of externally added recombinant heNOS (50 μg/mL; ALEXIS). Incubations were performed at 37°C. Data are shown as mean ± SEM. Asterisks indicate statistically significant difference between incubation time 0 minutes and incubation time 10 minutes (P = .029), incubation time 20 minutes (P = .021) and incubation time 30 minutes (P = .016). (D) Decrease in the concentration of externally added NADPH (100μM) in lyzed RBCs diluted with phosphate buffered saline (1:200, vol/vol) after addition of the substrate GSSG (1mM). NADPH was measured spectrophotometrically by recording absorbance at 340 nm.

Close modal

We did not find [15N]nitrite and [15N]nitrate above baseline levels in lyzed RBCs from freshly obtained blood of 5 healthy volunteers on incubation with L-[15N2]-Arg (Figure 1C). In contrast, external addition of a recombinant human eNOS (heNOS) resulted in formation of [15N]nitrate indicating functional heNOS activity in lyzed RBCs. Addition of NADPH to lyzed RBCs did not further increase heNOS activity suggesting that sufficient endogenous NADPH is present in the hemolysate (Figure 1C). heNOS activity in buffer was found not to differ for H4B concentrations between 100 and 2500nM.11  That heNOS activity was measurable in lyzed RBCs suggest that H4B is present in lyzed and native RBCs at concentrations high enough to ensure NOS activity. In addition, we found that glutathione reductase (GR), which shares with NOS the cofactors NADPH and FAD, was active in lyzed RBCs (Figure 1D). This finding suggests that other pathways are intact and functional in the lyzed RBCs used in the present study.

We used a sophisticated GC-MS assay to measure NOS activity in human RBCs. Our results suggest that human RBCs either contain inactive eeNOS or eeNOS activity is very low. The physiologic function of eeNOS in human erythrocytes is elusive and remains to be established.

Acknowledgments: This study was supported by the Deutsche Forschungsgemeinschaft (TS 60/4-1). The authors thank Frank-Mathias Gutzki for performing GC-MS analyses.

Contribution: A.B., J.S., and D.T. wrote the manuscript; and A.B., B.B., and J.S. performed the laboratory work.

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Correspondence: Prof Dimitrios Tsikas, Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Str 1, 30625 Hannover, Germany; e-mail: tsikas.dimitros@mh-hannover.de.

1
Daff
 
S
NO synthase: Structures and mechanisms.
Nitric Oxide
2010
, vol. 
23
 
1
(pg. 
1
-
11
)
2
Deliconstantinos
 
G
Villiotou
 
V
Stavrides
 
JC
et al. 
Nitric oxide and peroxynitrite production by human erythrocytes: a causative factor of toxic anemia in breast cancer patients.
Anticancer Res
1995
, vol. 
15
 
4
(pg. 
1435
-
1446
)
3
Chen
 
LY
Mehta
 
JL
Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function.
J Cardiovasc Pharmacol
1998
, vol. 
32
 
1
(pg. 
57
-
61
)
4
Kang
 
ES
Ford
 
K
Grokulsky
 
G
et al. 
Normal circulating adult human red blood cells contain inactive NOS proteins.
J Lab Clin Med
2000
, vol. 
135
 
6
(pg. 
444
-
451
)
5
Kleinbongard
 
P
Schulz
 
R
Rassaf
 
T
et al. 
Red blood cells express a functional endothelial nitric oxide synthase.
Blood
2006
, vol. 
107
 
7
(pg. 
2943
-
2951
)
6
Gladwin
 
MT
Does eNOS stand for erythrocytic NO synthase?
Blood
2006
, vol. 
107
 
7
(pg. 
2595
-
2596
)
7
Chen
 
K
Popel
 
AS
Nitric oxide production pathways in erythrocytes and plasma.
Biorheology
2009
, vol. 
46
 
2
(pg. 
107
-
119
)
8
Ulker
 
P
Yaras
 
N
Yalcin
 
O
et al. 
Shear stress activation of nitric oxide synthase and increased nitric oxide levels in human red blood cells.
Nitric Oxide
2011
, vol. 
24
 
4
(pg. 
184
-
191
)
9
Tsikas
 
D
A critical review and discussion of analytical methods in the L-arginine/nitric oxide area of basic and clinical research.
Anal Biochem
2008
, vol. 
379
 
2
(pg. 
139
-
163
)
10
Tsikas
 
D
Measurement of nitric oxide synthase activity in vivo and in vitro by gas chromatography-mass spectrometry.
Methods Mol Biol
2004
, vol. 
279
 (pg. 
81
-
103
)
11
Tsikas
 
D
Bohmer
 
A
Fentje
 
M
Tetrahydrobiopterin and endothelial nitric oxide synthase uncoupling [published online ahead of print January 3, 2012].
Hypertension
 
Sign in via your Institution